ibrutinib
janssen,abbvie
['mantle,(-dismantle)', 'ibru', 'lymphoma']
the largest trial to date in mantle cell #lymphoma shows that adding the btk inhibitor ibrutinib to soc treatment improves pfs by 50%. #asco22 #asco2022
Medscape provides breaking medical news and expert perspectives, drug and disease information, and free CME across 30+ medical specialties.